eMedicine World Medical Library

Excerpt from Developmental Dysplasia of the Hip


Synonyms, Key Words, and Related Terms: DDH, developmental dislocation of the hip, congenital dislocation of the hip, CDH, hip dysplasia, hip subluxation, hip dislocation, teratologic hip dislocation, hip instability, displaced hip, dislocated hip, cerebral palsy, myelomeningocele, arthrogryposis, Larsen syndrome, proximal femoral focal deficiency, Charcot-Marie-Tooth disease, Ortolani maneuver, Galeazzi sign

Please click here to view the full topic text: Developmental Dysplasia of the Hip

The term congenital dislocation of the hip dates back to the time of Hippocrates. This condition, also known as hip dysplasia or developmental dysplasia of the hip (DDH), has been diagnosed and treated for several hundred years. Most notably, Ortolani, an Italian pediatrician in the early 1900s, evaluated, diagnosed, and began treating hip dysplasia.1 Galeazzi later reviewed more than 12,000 cases of DDH and reported the association between apparent shortening of the flexed femur and hip dislocation. Since then, significant progress has been made in the evaluation and treatment of DDH.

Related eMedicine topics:
Developmental Dysplasia of the Hip [in the Radiology section]
Dislocation, Hip
Limping Child
Slipped Capital Femoral Epiphysis
Snapping Hip Syndrome

Related Medscape topics:
Resource Center Joint Disorders
Resource Center Neonatal Medicine
Specialty Site Orthopaedics
Specialty Site Pediatrics
CME/CE Best Evidence Review - Supplementation With Calcium and Vitamin D: Efficacy Against Fracture and Total Mortality: A Best Evidence Review
Operative and Non-operative Treatment Options for Dislocation of the Hip Following Total Hip Arthroplasty

Problem

The definition of DDH is not universally agreed upon. According to Webster's Third New International Dictionary, dysplasia is defined as abnormal growth or development, thus making the term DDH somewhat redundant.2 Typically, the term DDH is used when referring to patients who are born with dislocation or instability of the hip, which may then result in hip dysplasia.

A broader definition of DDH is simply abnormal growth of the hip. Abnormal development of the hip includes the osseous structures, such as the acetabulum and the proximal femur, and the labrum, capsule, and other soft tissues. This condition may occur at any time, from conception to skeletal maturity. The author prefers to use the term hip dysplasia because he believes this term is simpler and more accurate. Internationally, this disorder is still referred to as congenital dislocation of the hip.

More specific terms are often used to better describe the condition; these are defined as follows:

  • Subluxation – This is incomplete contact between the articular surfaces of the femoral head and acetabulum.
  • Dislocation – This refers to complete loss of contact between the articular surface of the femoral head and acetabulum.
  • Instability – This consists of the ability to subluxate or dislocate the hip with passive manipulation.
  • Teratologic dislocation – This refers to antenatal dislocation of the hip.

Frequency

The overall frequency of DDH is usually reported as approximately 1 case per 1000 individuals, although Barlow believed that the incidence of hip instability during newborn examinations was as high as 1 case per 60 newborns.3 According to his study, more than 60% of hip instability became stable by age 1 week, and 88% became stable by age 2 months, leaving only 12% (of the 1 in 60 newborns, or 0.2%) with residual hip instability.3

Etiology

The etiology of hip dysplasia is not clear, but this condition does appear to be related to a number of different factors.4 One such factor is racial background; among Native Americans and Laplanders, the prevalence of hip dysplasia is much higher (nearly 25-50 cases per 1000 persons) than other races, and the prevalence is very low among southern Chinese and black populations.5, 6, 7, 8 An underlying genetic disposition also appears to exist in that a 10-fold increase in the frequency of hip dysplasia occurs in children whose parents had DDH compared with those whose parents did not.9

Other factors possibly related to DDH include intrauterine positioning and sex, and some of these are interrelated. Female sex, being the first-born child, and breech positioning are all associated with an increased prevalence of DDH. An estimated 80% of persons with DDH are female,10 and the rate of breech positioning in children with DDH is approximately 20% (compared with 2-4% in the general population).11, 12 The prevalence of DDH in females born in breech position has been estimated to be as high as 1 case in 15 persons in some studies.13

Other musculoskeletal disorders of intrauterine malpositioning or crowding, such as metatarsus adductus and torticollis, have been reported to be associated with DDH.14, 15 Oligohydramnios is also reported to be associated with an increased prevalence of DDH.16 The left hip is more commonly associated with DDH than the right, and this is believed to be due to the common intrauterine position of the left hip against the mother's sacrum, forcing it into an adducted position.16 Children in cultures in which the mother swaddles the baby, forcing the infant's hips to be adducted, also have a higher rate of hip dysplasia.17

Hip dysplasia can be associated with underlying neuromuscular disorders, such as cerebral palsy, myelomeningocele, arthrogryposis, and Larsen syndrome, although these are not usually considered DDH.

Pathophysiology

DDH involves abnormal growth of the hip. Ligamentous laxity is also believed to be associated with hip dysplasia, although this association is less clear. DDH is not part of the classic description of disorders that are associated with significant ligamentous laxity, such as Ehlers-Danlos syndrome or Marfan syndrome.

Children often have ligamentous laxity at birth, yet their hips are not usually unstable; in fact, it takes a great deal of effort to dislocate a child's hip. Therefore, more than just ligamentous laxity may be required to result in DDH. At birth, white children tend to have a shallow acetabulum.18, 19; this may provide a susceptible period in which abnormal positioning or a brief period of ligamentous laxity may result in hip instability. However, this characteristic is not as true for children of black descent, who have a lower rate of DDH.8

Related Medscape topics:
Resource Center Neonatal Medicine
Specialty Site Orthopaedics
Specialty Site Pediatrics

Clinical

Early clinical manifestations of DDH are identified during examination of the newborn. The classic examination finding is revealed with the Ortolani maneuver; a palpable "clunk" is present when the hip is reduced in and out of the acetabulum and over the neolimbus. A high-pitched "click" (as opposed to a clunk) in all likelihood has little association with acetabular pathology.20, 21 Ortolani originally described this clunk as occurring with either subluxation or reduction of the hip (in or out of the acetabulum). More commonly, the Ortolani sign is referred to as a clunk, felt when the hip reduces into the acetabulum, with the hip in abduction.

To perform this maneuver correctly, the patient must be relaxed. Only one hip is examined at a time. The examiner's thumb is placed over the patient's inner thigh, and the index finger is gently placed over the greater trochanter. The hip is abducted, and gentle pressure is placed over the greater trochanter. In the presence of DDH, a clunk, similar to turning a light switch on or off, is felt when the hip is reduced. The Ortolani maneuver should be performed gently, such that the fingertips do not blanch.1

Barlow described another test for DDH that is performed with the hips in an adducted position, in which slight gentle posterior pressure is applied to the hips. A clunk should be felt as the hip subluxes out of the acetabulum.3

The clinical examination for late DDH, when the child is aged 3-6 months, is quite different. At this point, the hip, if dislocated, is often dislocated in a fixed position.9 The Galeazzi sign is a classic identifying sign for unilateral hip dislocation (see Image 1). This is performed with the patient lying supine and the hips and knees flexed. The examination should demonstrate that one leg appears shorter than the other. Although this finding is usually due to hip dislocation, realizing that any limb-length discrepancy results in a positive Galeazzi sign is important.

Additional physical examination findings for late dislocation include asymmetry of the gluteal thigh or labral skin folds, decreased abduction on the affected side, standing or walking with external rotation, and leg-length inequality.

Bilateral dislocation of the hip, especially at a later age, can be quite difficult to diagnose. This condition often manifests as a waddling gait with hyperlordosis. Many of the aforementioned clues for a unilateral dislocated hip are not present, such as the Galeazzi sign, asymmetrical thigh and skin folds, or asymmetrically decreased abduction. Careful examination is needed, and a high level of suspicion is important.

Note: Any limp in a child should be considered abnormal. The diagnosis can be quite variable, but an underlying etiology must always be pursued.

Of primary importance is making the diagnosis of hip dislocation or dysplasia. Once this diagnosis is made, the patient should be examined to be sure there is no underlying medical or neuromuscular disorder. Proximal femoral focal deficiency can masquerade as hip dysplasia and often manifests similarly. Because the femoral head does not ossify, the radiographic appearance also may be deceiving. Other neuromuscular disorders can manifest as dysplasia later in life, such as Charcot-Marie-Tooth disease.

Please click here to view the full topic text: Developmental Dysplasia of the Hip

About Us | Privacy | Code of Ethics | Terms of Use | Contact Us | Advertising | Institutional Subscribers
Labelled with ICRA © 1996-2006 by WebMD.
All Rights Reserved.

Medicine is a constantly changing science and not all therapies are clearly established. New research changes drug and treatment therapies daily. The authors, editors, and publisher of this journal have used their best efforts to provide information that is up-to-date and accurate and is generally accepted within medical standards at the time of publication. However, as medical science is constantly changing and human error is always possible, the authors, editors, and publisher or any other party involved with the publication of this article do not warrant the information in this article is accurate or complete, nor are they responsible for omissions or errors in the article or for the results of using this information. The reader should confirm the information in this article from other sources prior to use. In particular, all drug doses, indications, and contraindications should be confirmed in the package insert. FULL DISCLAIMER